Statins in chronic kidney disease: time to move on?
Crossref DOI link: https://doi.org/10.1038/nrneph.2015.36
Published Online: 2015-03-24
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Haynes, Richard
Wanner, Christoph
Text and Data Mining valid from 2015-03-24
Article History
First Online: 24 March 2015
Competing interests
: C.W. has received lecture honoraria and travel assistance from Amgen, Sanofi, and Merck Sharp & Dohme. R.H. declares no competing interests.